A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg
tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz
Pharma) following a single oral dose (1 x 15mg tablet) in healthy, adult subjects under
fasting conditions.